These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 27440209)

  • 1. Highlights from the 2016 Schizophrenia International Research Society Conference, April 2-6, 2016.
    Solis M
    Clin Schizophr Relat Psychoses; 2016; 10(2):89-92. PubMed ID: 27440209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highlights from the 2014 Schizophrenia International Research Society Conference April 5-9, 2014.
    Curley AA
    Clin Schizophr Relat Psychoses; 2014 Jul; 8(2):81-3. PubMed ID: 25061011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highlights from the 2012 Schizophrenia International Research Society Conference, April 14-18, 2012.
    Heimer H; Solis M
    Clin Schizophr Relat Psychoses; 2012 Jul; 6(2):55-60. PubMed ID: 22776631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highlights from the Biennial International Congress on Schizophrenia Research (ICOSR), March 24-March 28, 2017.
    Heimer H
    Clin Schizophr Relat Psychoses; 2017; 11(2):91-94. PubMed ID: 28742395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A proof-of-concept, randomized controlled trial of DAR-0100A, a dopamine-1 receptor agonist, for cognitive enhancement in schizophrenia.
    Girgis RR; Van Snellenberg JX; Glass A; Kegeles LS; Thompson JL; Wall M; Cho RY; Carter CS; Slifstein M; Abi-Dargham A; Lieberman JA
    J Psychopharmacol; 2016 May; 30(5):428-35. PubMed ID: 26966119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highlights from the new drug session at the Biennial International Congress On Schizophrenia Research, April 2-6, 2011.
    Heimer H
    Clin Schizophr Relat Psychoses; 2011 Jul; 5(2):72-4. PubMed ID: 21693429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single 20 mg dose of the full D1 dopamine agonist dihydrexidine (DAR-0100) increases prefrontal perfusion in schizophrenia.
    Mu Q; Johnson K; Morgan PS; Grenesko EL; Molnar CE; Anderson B; Nahas Z; Kozel FA; Kose S; Knable M; Fernandes P; Nichols DE; Mailman RB; George MS
    Schizophr Res; 2007 Aug; 94(1-3):332-41. PubMed ID: 17596915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulsatile administration of D1 but not D2 dopamine agonists induces behavioral tolerance in MPTP-treated monkeys.
    Luquin MR; Guillén J; Legarda I; Cruz Rodriguez M; Del Rio L; Dominguez J; Martínez-Lage JM
    Adv Neurol; 1996; 69():239-44. PubMed ID: 8615134
    [No Abstract]   [Full Text] [Related]  

  • 9. Partial agonism and schizophrenia.
    Bolonna AA; Kerwin RW
    Br J Psychiatry; 2005 Jan; 186():7-10. PubMed ID: 15630117
    [No Abstract]   [Full Text] [Related]  

  • 10. Schizophrenia research: a biennium of progress. Proceedings from the Sixth International Congress on Schizophrenia Research. Colorado Springs, CO, April 12-16, 1997.
    Buchanan RW; Buckley PF; Tamminga CA; Schulz SC
    Schizophr Bull; 1998; 24(4):501-18. PubMed ID: 9853785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single 20 mg dose of dihydrexidine (DAR-0100), a full dopamine D1 agonist, is safe and tolerated in patients with schizophrenia.
    George MS; Molnar CE; Grenesko EL; Anderson B; Mu Q; Johnson K; Nahas Z; Knable M; Fernandes P; Juncos J; Huang X; Nichols DE; Mailman RB
    Schizophr Res; 2007 Jul; 93(1-3):42-50. PubMed ID: 17467956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highlights from the Biennial International Congress on Schizophrenia Research (ICOSR), April 21-25, 2013.
    Curley AA; Fisher HL
    Clin Schizophr Relat Psychoses; 2013; 7(2):68-72. PubMed ID: 23841955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Antipsychotic Dose Reduction in Late-Life Schizophrenia: A Prospective Dopamine D2/3 Receptor Occupancy Study.
    Graff-Guerrero A; Rajji TK; Mulsant BH; Nakajima S; Caravaggio F; Suzuki T; Uchida H; Gerretsen P; Mar W; Pollock BG; Mamo DC
    JAMA Psychiatry; 2015 Sep; 72(9):927-34. PubMed ID: 26131622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frontal D2/3 Receptor Availability in Schizophrenia Patients Before and After Their First Antipsychotic Treatment: Relation to Cognitive Functions and Psychopathology.
    Nørbak-Emig H; Ebdrup BH; Fagerlund B; Svarer C; Rasmussen H; Friberg L; Allerup PN; Rostrup E; Pinborg LH; Glenthøj BY
    Int J Neuropsychopharmacol; 2016 May; 19(5):. PubMed ID: 26819282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of dopamine D1 and D2 receptor agonists on schedule-controlled behavior of squirrel monkeys.
    Bergman J; Rosenzweig-Lipson S; Spealman RD
    J Pharmacol Exp Ther; 1995 Apr; 273(1):40-8. PubMed ID: 7714795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic polymorphisms in dopaminergic system and treatment-resistant schizophrenia.
    Terzić T; Kastelic M; Dolžan V; Plesničar BK
    Psychiatr Danub; 2016 Jun; 28(2):127-31. PubMed ID: 27287786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A dopaminergic deficit hypothesis of schizophrenia: the path to discovery.
    Carlsson A; Carlsson ML
    Dialogues Clin Neurosci; 2006; 8(1):137-42. PubMed ID: 16640125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COMT val158met moderation of dopaminergic drug effects on cognitive function: a critical review.
    Schacht JP
    Pharmacogenomics J; 2016 Oct; 16(5):430-8. PubMed ID: 27241058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine D1 rather than D2 receptor agonists disrupt prepulse inhibition of startle in mice.
    Ralph-Williams RJ; Lehmann-Masten V; Geyer MA
    Neuropsychopharmacology; 2003 Jan; 28(1):108-18. PubMed ID: 12496946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impacts of dopamine D2 receptor polymorphism and antipsychotic dosage on dopamine supersensitivity psychosis in schizophrenia.
    Takase M; Kanahara N; Oda Y; Niitsu T; Watanabe H; Iyo M
    Schizophr Res; 2017 Dec; 190():182-183. PubMed ID: 28285026
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.